eConsent: Busting Regulatory Myths

One of the major obstacles for researchers when deciding whether to adopt an eConsent approach within their study has been a lack of understanding surrounding regulatory support. While many would believe that there is little or no regulatory support for this innovative new technology, this is not actually the case. This article looks at some of the common misconceptions.

The article originally appeared on page 16 of the December 2018 edition of Pharmaceutical Market Europe.  

No Previous Flipbooks

Next Flipbook
An IRB Perspective on Improving Informed Consent
An IRB Perspective on Improving Informed Consent